122 related articles for article (PubMed ID: 10228365)
21. Vitek system antimicrobial susceptibility testing of O1, O139, and non-O1 Vibrio cholerae.
Sciortino CV; Johnson JA; Hamad A
J Clin Microbiol; 1996 Apr; 34(4):897-900. PubMed ID: 8815104
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic and genotypic characterization of Vibrio cholerae isolates from a recent cholera outbreak in Senegal: comparison with isolates from Guinea-Bissau.
Aidara A; Koblavi S; Boye CS; Raphenon G; Gassama A; Grimont F; Grimont PA
Am J Trop Med Hyg; 1998 Feb; 58(2):163-7. PubMed ID: 9502599
[TBL] [Abstract][Full Text] [Related]
23. [Cases of gastroenteritis associated to Vibrio cholerae no 01 in Oran, Salta].
Rivas M; Cacace ML; Ayala LT; Baschkier A; Miliwebsky E; Caffer MI
Rev Argent Microbiol; 1996; 28(4):163-9. PubMed ID: 9102658
[TBL] [Abstract][Full Text] [Related]
24. Class 1 integron-borne, multiple-antibiotic resistance encoded by a 150-kilobase conjugative plasmid in epidemic vibrio cholerae O1 strains isolated in Guinea-Bissau.
Dalsgaard A; Forslund A; Petersen A; Brown DJ; Dias F; Monteiro S; Molbak K; Aaby P; Rodrigues A; Sandström A
J Clin Microbiol; 2000 Oct; 38(10):3774-9. PubMed ID: 11015401
[TBL] [Abstract][Full Text] [Related]
25. A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139.
Waldor MK; Tschäpe H; Mekalanos JJ
J Bacteriol; 1996 Jul; 178(14):4157-65. PubMed ID: 8763944
[TBL] [Abstract][Full Text] [Related]
26. Emergence of tetracycline resistance due to a multiple drug resistance plasmid in Vibrio cholerae O139.
Yamamoto T; Nair GB; Takeda Y
FEMS Immunol Med Microbiol; 1995 Apr; 11(2):131-6. PubMed ID: 7640673
[TBL] [Abstract][Full Text] [Related]
27. Occurrence of resistance to vibriostatic compound 0/129 in Vibrio cholerae 01 isolated from clinical and environmental samples in Bangladesh.
Huq A; Alam M; Parveen S; Colwell RR
J Clin Microbiol; 1992 Jan; 30(1):219-21. PubMed ID: 1734056
[TBL] [Abstract][Full Text] [Related]
28. Molecular Epidemiology and Antibiotic Susceptibility of Vibrio cholerae Associated with a Large Cholera Outbreak in Ghana in 2014.
Eibach D; Herrera-León S; Gil H; Hogan B; Ehlkes L; Adjabeng M; Kreuels B; Nagel M; Opare D; Fobil JN; May J
PLoS Negl Trop Dis; 2016 May; 10(5):e0004751. PubMed ID: 27232338
[TBL] [Abstract][Full Text] [Related]
29. [Features of Vibrio cholerae 0:1 El Tor, Inaba serotype, isolated during the cholera epidemic in Cartagena (Colombia)].
Salim Máttar V
Enferm Infecc Microbiol Clin; 1992 Nov; 10(9):525-30. PubMed ID: 1489792
[TBL] [Abstract][Full Text] [Related]
30. High prevalence of multidrug-resistant strains of Vibrio cholerae, in a cholera outbreak in Tehran-Iran, during June-September 2008.
Ranjbar M; Rahmani E; Nooriamiri A; Gholami H; Golmohamadi A; Barati H; Rajabifar D; Barati S; Sabet MS; Zamiri A; Haghighi S; Taifehashemi P; Nojomi M
Trop Doct; 2010 Oct; 40(4):214-6. PubMed ID: 20709810
[TBL] [Abstract][Full Text] [Related]
31. Serovar, biotype, phage type, toxigenicity & antibiotic susceptibility patterns of Vibrio cholerae isolated during two consecutive cholera seasons (1989-90) in Calcutta.
Ramamurthy T; Pal A; Bhattacharya MK; Bhattacharya SK; Chowdhury AS; Takeda Y; Takeda T; Pal SC; Nair GB
Indian J Med Res; 1992 May; 95():125-9. PubMed ID: 1506061
[TBL] [Abstract][Full Text] [Related]
32. Emergence of multiply antibiotic-resistant Vibrio cholerae in Bangladesh.
Glass RI; Huq I; Alim AR; Yunus M
J Infect Dis; 1980 Dec; 142(6):939-42. PubMed ID: 7462703
[TBL] [Abstract][Full Text] [Related]
33. Evolutionary genetic analysis of the emergence of epidemic Vibrio cholerae isolates on the basis of comparative nucleotide sequence analysis and multilocus virulence gene profiles.
O'Shea YA; Reen FJ; Quirke AM; Boyd EF
J Clin Microbiol; 2004 Oct; 42(10):4657-71. PubMed ID: 15472325
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a clinical Vibrio cholerae O139 isolate from Mexico.
Parveen S; Farrah SR; Gonzalez-Bonilla C; Zamudio AV; Tamplin ML
Can J Microbiol; 2003 Jan; 49(1):65-70. PubMed ID: 12674350
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic and genetic characterization of Vibrio cholerae O1 isolated from various regions of Kenya between 2007 and 2010.
Mercy N; Mohamed AA; Zipporah N; Chowdhury G; Pazhani GP; Ramamurthy T; Boga HI; Kariuki SM; Joseph O
Pan Afr Med J; 2014; 19():8. PubMed ID: 25584121
[TBL] [Abstract][Full Text] [Related]
36. Serotypes of Vibrio cholerae non-O1 isolated from water supplies for human consumption in Campeche, México and their antibiotic susceptibility pattern.
Isaac-Márquez AP; Lezama-Dávila CM; Eslava-Campos C; Navarro-Ocaña A; Cravioto-Quintana A
Mem Inst Oswaldo Cruz; 1998; 93(1):17-22. PubMed ID: 9698837
[TBL] [Abstract][Full Text] [Related]
37. Gastroenteritis due to Vibrio cholerae El-Tor Ogawa in Dhule.
Nitsure S; Dravid M; Jaffari LA; Anvikar AR
Indian J Med Sci; 1997 Nov; 51(11):417-9. PubMed ID: 9567501
[TBL] [Abstract][Full Text] [Related]
38. Survey of in vitro susceptibilities of Vibrio cholerae O1 and O139 to antimicrobial agents.
Yamamoto T; Nair GB; Albert MJ; Parodi CC; Takeda Y
Antimicrob Agents Chemother; 1995 Jan; 39(1):241-4. PubMed ID: 7695314
[TBL] [Abstract][Full Text] [Related]
39. [Characteristics of the cholera epidemic of 1998 in Ecuador during El Niño].
Gabastou JM; Pesantes C; Escalante S; Narváez Y; Vela E; García L; Zabala D; Yadon ZE
Rev Panam Salud Publica; 2002 Sep; 12(3):157-64. PubMed ID: 12396633
[TBL] [Abstract][Full Text] [Related]
40. [Resistance of Vibrio cholerae 0:1 to the 0/129 compound and multiresistance to antibiotics].
Bougoudogo F; Fournier JM; Gastellu-Etchegorry M; Guillou M; Dodin A
Bull Soc Pathol Exot; 1992; 85(2):136-41. PubMed ID: 1327350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
